Hydroxylated long-chain acylcarnitines are biomarkers of mitochondrial myopathy

Abstract

In conclusion, elevated concentrations of acylcarnitines is common in patients with mitochondrial myopathy and shows a specific pattern affecting hydroxylated long-chain acylcarnitines, which can have implications for future diagnostic workup of patients.